Compounded Semaglutide (GLP-1)
US$ 20.95
keep weight off after tirzepatide Delivers Long-Term Loss — and the Numbers Prove It If you're struggling with weight and have prediabetes, a breakthrough treatment may offer lasting results. New data from the SURMOUNT-1 trial Can You Keep Weight Off
Description
This is not a sales pitch
Survodutide (BI 456906), a novel dual GLP-1 and glucagon receptor agonist, demonstrated weight loss of up to 18.7% over 46 weeks in overweight or obese people
24.4%, P=0.001) than those with normal GET
Highest trial efficacy.
Directions: Simply wear a band on each wrist for as long as needed, with the button placed face-down over the Nei-Kuan point
Semaglutide has shown promise in reducing sleep apnea severity through weight loss and improved airway function
